Nucleoside analogs with carboxamidine modified monocyclic base

Details Nucleoside analogs with carboxamidine modified monocyclic base Nucleoside analogs with carboxamidine modified monocyclic base

A - Human Necessities

61

K

A61K 31/70 (2006.01) A01N 43/04 (2006.01) C07H 19/056 (2006.01) C07H 19/14 (2006.01)

Patent

CA 2399208

Novel nucleoside analog compounds are disclosed. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 and Type 2 activity.

L'invention concerne de nouveaux composés d'analogues nucléosidiques. Les nouveaux composés, les esters ou les sels pharmaceutiquement acceptables de ceux-ci peuvent être utilisés dans des compositions pharmaceutiques et peuvent servir à traiter une infection, une infestation, un néoplasme ou une maladie auto-immune. Les nouveaux composés peuvent également être utilisés pour moduler des aspects du système immunitaire, y compris la modulation d'activités de type 1 et de type 2.

Affiliated with

Also associated with

Rating

Nucleoside analogs with carboxamidine modified monocyclic base does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleoside analogs with carboxamidine modified monocyclic base, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside analogs with carboxamidine modified monocyclic base will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1794691